AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
DIAGNOSIS OF VON-WILLEBRAND-DISEASE
Authors: FEDERICI AB
Citation: Ab. Federici, DIAGNOSIS OF VON-WILLEBRAND-DISEASE, Haemophilia, 4(4), 1998, pp. 654-660
LOW PLATELET ALPHA-2-BETA-1 LEVELS IN PATIENTS WITH TYPE-1 VON-WILLEBRAND-DISEASE REPRESENT AN INCREASED RISK FACTOR FOR BLEEDING
Authors: FEDERICI AB MANNUCCI PM CANCIANI MT COZZI G DIPAOLA J KUNICKI TJ NUGENT D
Citation: Ab. Federici et al., LOW PLATELET ALPHA-2-BETA-1 LEVELS IN PATIENTS WITH TYPE-1 VON-WILLEBRAND-DISEASE REPRESENT AN INCREASED RISK FACTOR FOR BLEEDING, Thrombosis research, 91(3), 1998, pp. 9-9
ACTUAL MANAGEMENT OF VON-WILLEBRAND-DISEASE (VWD) - REPORT ON 1357 CASES OF THE NATIONAL-REGISTRY-OF-VON-WILLEBRAND-DISEASE (RENAWI)
Authors: FEDERICI AB MANNUCCI PM
Citation: Ab. Federici et Pm. Mannucci, ACTUAL MANAGEMENT OF VON-WILLEBRAND-DISEASE (VWD) - REPORT ON 1357 CASES OF THE NATIONAL-REGISTRY-OF-VON-WILLEBRAND-DISEASE (RENAWI), Thrombosis research, 91(3), 1998, pp. 10-10
EVALUATION OF THE VON-WILLEBRAND-FACTOR-COLLAGEN BINDING-ACTIVITY (VWF-CBA) IN 74 PATIENTS WITH DIFFERENT TYPES OF VON-WILLEBRAND-DISEASE -COMPARISON WITH THE RISTOCETIN COFACTOR ACTIVITY
Authors: CANCIANI MT FEDERICI AB GHELFI E FORZA I MANNUCCI PM
Citation: Mt. Canciani et al., EVALUATION OF THE VON-WILLEBRAND-FACTOR-COLLAGEN BINDING-ACTIVITY (VWF-CBA) IN 74 PATIENTS WITH DIFFERENT TYPES OF VON-WILLEBRAND-DISEASE -COMPARISON WITH THE RISTOCETIN COFACTOR ACTIVITY, Thrombosis research, 91(3), 1998, pp. 27-27
EVALUATION OF PLATELET-FUNCTION WITH PFA-100(R) IN PATIENTS WITH CONGENITAL PLATELET SECRETION DEFECTS
Authors: LECCHI A CATTANEO M AGATI B LOMBARDI R FEDERICI AB MOSTARDA G MANNUCCI PL
Citation: A. Lecchi et al., EVALUATION OF PLATELET-FUNCTION WITH PFA-100(R) IN PATIENTS WITH CONGENITAL PLATELET SECRETION DEFECTS, Thrombosis research, 91(3), 1998, pp. 32-32
EVALUATION OF PLATELET-FUNCTION IN VON-WILLEBRAND-DISEASE WITH PFA-100(R)
Authors: AGATI B CATTANEO M FEDERICI AB LECCHI A STABILE F LOMBARDI R CANCIANI MT MANNUCCI PM
Citation: B. Agati et al., EVALUATION OF PLATELET-FUNCTION IN VON-WILLEBRAND-DISEASE WITH PFA-100(R), Thrombosis research, 91(3), 1998, pp. 34-34
STUDIES OF MULTIMERIN IN PATIENTS WITH VON-WILLEBRAND DISEASE AND PLATELET VON-WILLEBRAND-FACTOR DEFICIENCY
Authors: CHEN CI FEDERICI AB CRAMER EM CANCIANI MT HARRISON P ZHENG SL MASSE JM MANNUCCI PM HAYWARD CPM
Citation: Ci. Chen et al., STUDIES OF MULTIMERIN IN PATIENTS WITH VON-WILLEBRAND DISEASE AND PLATELET VON-WILLEBRAND-FACTOR DEFICIENCY, British Journal of Haematology, 103(1), 1998, pp. 20-28
EVALUATION OF PLATELET-FUNCTION WITH PFA-100(R) IN PATIENTS WITH CONGENITAL PLATELET SECRETION DEFECTS
Authors: LECCHI A CATTANEO M AGATI B LOMBARDI R FEDERICI AB MOSTARDA G MANNUCCI PM
Citation: A. Lecchi et al., EVALUATION OF PLATELET-FUNCTION WITH PFA-100(R) IN PATIENTS WITH CONGENITAL PLATELET SECRETION DEFECTS, British Journal of Haematology, 102(1), 1998, pp. 285-285
EVALUATION OF PLATELET-FUNCTION IN VON-WILLEBRAND-DISEASE WITH PFA-100(R)
Authors: CATTANEO M FEDERICI AB AGATI B LECCHI A STABILE F LOMBARDI R CANCIANI MT MANNUCCI PM
Citation: M. Cattaneo et al., EVALUATION OF PLATELET-FUNCTION IN VON-WILLEBRAND-DISEASE WITH PFA-100(R), British Journal of Haematology, 102(1), 1998, pp. 368-368
TREATMENT OF ACQUIRED VON-WILLEBRAND-SYNDROME IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE - COMPARISON OF 3 DIFFERENT THERAPEUTIC APPROACHES
Authors: FEDERICI AB STABILE F CASTAMAN G CANCIANI MT MANNUCCI PM
Citation: Ab. Federici et al., TREATMENT OF ACQUIRED VON-WILLEBRAND-SYNDROME IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE - COMPARISON OF 3 DIFFERENT THERAPEUTIC APPROACHES, Blood, 92(8), 1998, pp. 2707-2711
TREATMENT OF ACQUIRED VON-WILLEBRAND-DISEASE IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE - BENEFITS AND LIMITS OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
Authors: FEDERICI AB STABILE F CASTAMAN G CANCIANI MT CAFRO AM DAMICO E RODEGHIERO F MANNUCCI PM
Citation: Ab. Federici et al., TREATMENT OF ACQUIRED VON-WILLEBRAND-DISEASE IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE - BENEFITS AND LIMITS OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN, Thrombosis and haemostasis, 1997, pp. 881-881
ASSOCIATION OF HEMOSTATIC PARAMETERS AND GASTRIC INFECTION BY HELICOBACTER-PYLORI - THE ROLE OF VON-WILLEBRAND-FACTOR
Authors: FEDERICI AB BOTTASSO B BIERTI L TAIOLI E CERNUSCHI C DEFRANCHIS R MANNUCCI PM
Citation: Ab. Federici et al., ASSOCIATION OF HEMOSTATIC PARAMETERS AND GASTRIC INFECTION BY HELICOBACTER-PYLORI - THE ROLE OF VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 1997, pp. 2221-2221
EVIDENCE FOR A FOUNDER EFFECT IN 38 ITALIAN AND INDIAN PATIENTS WITH TYPE-3 VON-WILLEBRAND-DISEASE
Authors: CANCIANI MT CROSTI F COZZI G TAIOLI E SHAJI RV SRIVASTAVA A FEDERICI AB
Citation: Mt. Canciani et al., EVIDENCE FOR A FOUNDER EFFECT IN 38 ITALIAN AND INDIAN PATIENTS WITH TYPE-3 VON-WILLEBRAND-DISEASE, Thrombosis and haemostasis, 1997, pp. 2674-2674
INVESTIGATION OF MULTIMERIN IN PATIENTS WITH PLATELET LOW TYPE-1 VON-WILLEBRAND-DISEASE
Authors: CHEN CI FEDERICI AB MANNUCCI PM HARRISON P ZHENG S HAYWARD CPM
Citation: Ci. Chen et al., INVESTIGATION OF MULTIMERIN IN PATIENTS WITH PLATELET LOW TYPE-1 VON-WILLEBRAND-DISEASE, Thrombosis and haemostasis, 1997, pp. 2677-2677
THE ROLE OF LOCAL THERAPY DURING ORAL-SURGERY IN PATIENTS WITH VON-WILLEBRAND-DISEASE - A RETROSPECTIVE ANALYSIS OF 46 CASES
Authors: SACCO R STABILE F CARPENEDO M CAFRO AM DAMICO E FEDERICI AB
Citation: R. Sacco et al., THE ROLE OF LOCAL THERAPY DURING ORAL-SURGERY IN PATIENTS WITH VON-WILLEBRAND-DISEASE - A RETROSPECTIVE ANALYSIS OF 46 CASES, Thrombosis and haemostasis, 1997, pp. 2845-2845
A TYPE 2B VAN-WILLEBRAND-DISEASE MUTATION (ILE(546)-]VAL) ASSOCIATED WITH AN UNUSUAL PHENOTYPE
Authors: FEDERICI AB MANNUCCI PM STABILE F CANCIANI MT DIROCCO N MIYATA S WARE J RUGGERI ZM
Citation: Ab. Federici et al., A TYPE 2B VAN-WILLEBRAND-DISEASE MUTATION (ILE(546)-]VAL) ASSOCIATED WITH AN UNUSUAL PHENOTYPE, Thrombosis and haemostasis, 78(3), 1997, pp. 1132-1137
LOW PLATELET ALPHA-2-BETA-1 LEVELS IN PATIENTS WITH VON-WILLEBRAND-DISEASE TYPE-I REPRESENTS AN INCREASED RISK FACTOR FOR BLEEDING
Authors: DIPAOLA J FEDERICI AB SACCHI E CANCIANI MT MANNUCCI PM KRITZIK M KUNICKI T NUGENT D
Citation: J. Dipaola et al., LOW PLATELET ALPHA-2-BETA-1 LEVELS IN PATIENTS WITH VON-WILLEBRAND-DISEASE TYPE-I REPRESENTS AN INCREASED RISK FACTOR FOR BLEEDING, Blood, 90(10), 1997, pp. 107-107
ACTUAL MANAGEMENT OF VON-WILLEBRAND-DISEASE (VWD) - FIRST REPORT ON 880 CASES OF THE ITALIAN REGISTRY OF VWD
Authors: FEDERICI AB MANNUCCI PM
Citation: Ab. Federici et Pm. Mannucci, ACTUAL MANAGEMENT OF VON-WILLEBRAND-DISEASE (VWD) - FIRST REPORT ON 880 CASES OF THE ITALIAN REGISTRY OF VWD, Blood, 90(10), 1997, pp. 132-132
STUDIES OF MULTIMERIN AND PLATELET ALPHA-GRANULAR PROTEINS IN PLATELET LOW TYPE-1 AND TYPE-3 VON-WILLEBRAND-DISEASE
Authors: CHEN CI FEDERICI AB CRAMER EM CANCIANI MT HARRISON P ZHENG S MASSE JM MANNUCCI PM HAYWARD CPM
Citation: Ci. Chen et al., STUDIES OF MULTIMERIN AND PLATELET ALPHA-GRANULAR PROTEINS IN PLATELET LOW TYPE-1 AND TYPE-3 VON-WILLEBRAND-DISEASE, Blood, 90(10), 1997, pp. 2659-2659
CONFORMATIONAL-CHANGES IN THE A1 DOMAIN OF VON-WILLEBRAND-FACTOR MODULATING THE INTERACTION WITH PLATELET GLYCOPROTEIN IB-ALPHA
Authors: MIYATA S GOTO S FEDERICI AB WARE J RUGGERI ZM
Citation: S. Miyata et al., CONFORMATIONAL-CHANGES IN THE A1 DOMAIN OF VON-WILLEBRAND-FACTOR MODULATING THE INTERACTION WITH PLATELET GLYCOPROTEIN IB-ALPHA, The Journal of biological chemistry, 271(15), 1996, pp. 9046-9053
PROTEOLYSIS OF VON-WILLEBRAND-FACTOR IS DECREASED IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID
Authors: FEDERICI AB FALANGA A LATTUADA A DIROCCO N BARBUI T MANNUCCI PM
Citation: Ab. Federici et al., PROTEOLYSIS OF VON-WILLEBRAND-FACTOR IS DECREASED IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID, British Journal of Haematology, 92(3), 1996, pp. 733-739
TREATMENT OF ACQUIRED VON-WILLEBRAND DISEASE IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE - BENEFITS AND LIMITS OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
Authors: FEDERICI AB STABILE F CASTAMAN G CANCIANI MT CAFRO AM RODEGHIERO F MANNUCCI PM
Citation: Ab. Federici et al., TREATMENT OF ACQUIRED VON-WILLEBRAND DISEASE IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE - BENEFITS AND LIMITS OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN, Blood, 88(10), 1996, pp. 149-149
ORTHOTOPIC LIVER-TRANSPLANTATION IN A PATIENT WITH SEVERE HEMOPHILIA-A - A LIFESAVING TREATMENT FOR THE FIRST ITALIAN CASE
Authors: FEDERICI AB MANNUCCI PM STABILE F ROSSI G PISEDDU G
Citation: Ab. Federici et al., ORTHOTOPIC LIVER-TRANSPLANTATION IN A PATIENT WITH SEVERE HEMOPHILIA-A - A LIFESAVING TREATMENT FOR THE FIRST ITALIAN CASE, International journal of clinical & laboratory research, 25(1), 1995, pp. 44-46
NEW MUTATION ILE(546)-]VAL IN A FAMILY WITH TYPE-IIB VON-WILLEBRAND DISEASE CHARACTERIZED BY SPONTANEOUS PLATELET-AGGREGATION, THROMBOCYTOPENIA AND NORMAL LEVELS OF RISTOCETIN COFACTOR
Authors: FEDERICI AB STABILE F CANCIANI MT MIYATA S WARE JL
Citation: Ab. Federici et al., NEW MUTATION ILE(546)-]VAL IN A FAMILY WITH TYPE-IIB VON-WILLEBRAND DISEASE CHARACTERIZED BY SPONTANEOUS PLATELET-AGGREGATION, THROMBOCYTOPENIA AND NORMAL LEVELS OF RISTOCETIN COFACTOR, Thrombosis and haemostasis, 73(6), 1995, pp. 1170-1170
INCREASED PROTEOLYSIS OF VON-WILLEBRAND-FACTOR IN ACUTE PROMYELOCYTICLEUKEMIA - PROGRESSIVE CORRECTION WITH TRANSIENT APPEARANCE OF SUPRANORMAL MULTIMERS FOLLOWING TREATMENT WITH ALL-TRANS-RETINOIC ACID
Authors: FEDERICI AB FALANGA A LATTUADA A DIROCCO N BARBUI T MANNUCCI PM
Citation: Ab. Federici et al., INCREASED PROTEOLYSIS OF VON-WILLEBRAND-FACTOR IN ACUTE PROMYELOCYTICLEUKEMIA - PROGRESSIVE CORRECTION WITH TRANSIENT APPEARANCE OF SUPRANORMAL MULTIMERS FOLLOWING TREATMENT WITH ALL-TRANS-RETINOIC ACID, Thrombosis and haemostasis, 73(6), 1995, pp. 1433-1433
Risultati: 1-25 | 26-38